Comments
Loading...

Lucid Diagnostics (LUCD) Stock Price, Quote, News & History

LUCDNASDAQ
Logo brought to you by Benzinga Data
$1.21
0.1413.08%
At close: Jan 23, 4:00 PM EST
$1.20
-0.01-0.83%
After Hours: Jan 23, 7:59 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$1.07
Close
$1.21
Volume / Avg.
2.56M / 1.17M
Day Range
$1.07 - $1.23
52 Wk Range
0.81 - 1.80
Market Cap
$157.32M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
5.03%
Days to Cover
7.17

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-43.78M
Investing Cash Flow (TTM)
-405.00K
Financing Cash Flow (TTM)
77.03M
Free Cash Flow (TTM)
-44.18M
Capital Expenditure (TTM)
-405.00K
Net Change in Cash (TTM)
32.84M

Analyst Trends and Forecast

1
Aug 25
2
Sep 25
1
Oct 25
1
Nov 25
1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$189.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
20.17
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-72.64%
Earnings Yield % (FWD)
-28.30%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.22

Company Debt

Total Debt
$22.30M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$47.33M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.07
Close
$1.21
Volume / Avg.
2.56M / 1.17M
Day Range
$1.07 - $1.23
52 Wk Range
0.81 - 1.80
Market Cap
$157.32M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
5.03%
Days to Cover
7.17

About

Sector
Health Care
Industry
Health Care Equipment & Supplies
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LUCD
LNSR

FAQ

Q

How do I buy Lucid Diagnostics (LUCD) stock?

A

You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lucid Diagnostics (LUCD) competitors?

Q

What is the forecast, or price target, for Lucid Diagnostics (LUCD) stock?

A

Lucid Diagnostics has a consensus price target of $3.79.

Q

What is the current price for Lucid Diagnostics (LUCD)?

A

The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $1.2 last updated January 23, 2026 at 7:59 PM EST.

Q

Does Lucid Diagnostics (LUCD) pay a dividend?

A

There are no upcoming dividends for Lucid Diagnostics.

Q

When is Lucid Diagnostics (NASDAQ:LUCD) reporting earnings?

A

Lucid Diagnostics does not have any upcoming earnings scheduled.

Q

Is Lucid Diagnostics (LUCD) going to split?

A

There is no upcoming split for Lucid Diagnostics.

Q

What sector and industry does Lucid Diagnostics (LUCD) operate in?

A

Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.